|
Market Closed -
Other stock markets
|
Pre-market 06:26:43 | |||
| 154.21 USD | -0.15% |
|
156.40 | +1.42% |
| 08-05 | Sandoz gains on strong biosimilar growth, touts 'golden decade' | RE |
| 08-03 | Correction to Novartis Wins FDA Approval for Expanded Prostate Cancer Treatment Article on July 31 | DJ |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NOVARTIS AG | Other Pharmaceuticals | -0.15% | -2.67% | +11.85% | +35.87% | +68.87% | 293B |  | |  |
- Stock Market
- Stocks
- NOVN Stock
- NVS Stock
- Charts Novartis AG
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
